logo
ResearchBunny Logo
Activatable polymer nanoagonist for second near-infrared photothermal immunotherapy of cancer

Medicine and Health

Activatable polymer nanoagonist for second near-infrared photothermal immunotherapy of cancer

Y. Jiang, J. Huang, et al.

Discover the groundbreaking research by Yuyan Jiang, Jiaguo Huang, Cheng Xu, and Kanyi Pu on a novel photothermally activatable polymeric pro-nanoagonist (APNA) that enhances combinational photothermal immunotherapy for cancer. This innovative approach utilizes deep-tissue-penetrating NIR-II light to trigger tumor ablation and boost systemic antitumor immunity.

00:00
00:00
Playback language: English
Abstract
This paper reports a photothermally activatable polymeric pro-nanoagonist (APNA) for combinational photothermal immunotherapy of cancer, specifically regulated by deep-tissue-penetrating second near-infrared (NIR-II) light. APNA, composed of an immunostimulant (Resiquimod: R848) covalently conjugated to a NIR-II semiconducting transducer via a thermo-responsive linker, mediates photothermal effects upon NIR-II irradiation. This triggers tumor ablation, immunogenic cell death, and linker cleavage, liberating the agonist for in-situ immune activation. This controlled immune regulation enhances systemic antitumor immunity, inhibiting metastasis.
Publisher
Nature Communications
Published On
Feb 02, 2021
Authors
Yuyan Jiang, Jiaguo Huang, Cheng Xu, Kanyi Pu
Tags
photothermal therapy
cancer immunotherapy
NIR-II light
polymeric pro-nanoagonist
systemic immunity
tumor ablation
immunogenic cell death
Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 12+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny